Veristat and TOPRA hosted a webinar on the topic: Future Trends on European Regulations on Medicines
Webinar | Orphan Drug Designation
August 29, 2022
Orphan Drug Designation - The Considerations, The Rewards, and How They Differ Between The US and Europe
Recording available now!
Improving the patient experience while overcoming DCT challenges for a pediatric rare disease population
Webinar | Strategies for Solving the Challenges of an Extraordinary Natural History Study
May 16, 2022
Navigating the Patient Experience When Pivoting to a Virtual Model Mid-Study
On-Demand Webinar
On-Demand Webinar | What's New in Draft MHPD Guidance on Reporting Adverse Reactions for Marketed Products
April 12, 2021
Certus PV, a Veristat Company experts recently lead an Xtalks webinar - View it On-Demand Now
Veristat experts recently led an Xtalks webinar on lessons learned for planning decentralized clinical trials.
Webinar | Roadmap to Market for Cell and Gene Therapies
October 12, 2020
View the On-Demand Webinar
Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.
Webinar | Reducing Study Build Time from Weeks to Days
October 1, 2020
View Webinar On-Demand
Study start-up and post-go-live protocol amendments can be lengthy, costly, and disruptive to a clinical trial. But with the right technology, data managers can accelerate timelines and overcome these challenges.
Webinar | Minimize Disruption of Your Oncology Trial
June 4, 2020
View the On-Demand Webinar
View the On-Webinar
